The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
- PMID: 8890165
- PMCID: PMC452229
The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
Abstract
Vascular endothelial growth factor (VEGF) is an angiogenic inducer that mediates its effects through two high affinity receptor tyrosine kinases, Flt-1 and KDR. Flt-1 is required for endothelial cell morphogenesis whereas KDR is involved primarily in mitogenesis. Flt-1 has an alternative ligand, placenta growth factor (PlGF). Both Flt-1 and KDR have seven immunoglobulin (Ig)-like domains in the extracellular domain. The significance and function of these domains for ligand binding and receptor activation are unknown. Here we show that deletion of the second domain of Flt-1 completely abolishes the binding of VEGF. Introduction of the second domain of KDR into an Flt-1 mutant lacking the homologous domain restored VEGF binding. However, the ligand specificity was characteristic of the KDR receptor. We then created chimeric receptors where the first three or just the second Ig-like domains of Flt-1 replaced the corresponding domains in Flt-4, a receptor that does not bind VEGF, and analyzed their ability to bind VEGF. Both swaps conferred upon Flt-4 the ability to bind VEGF with an affinity nearly identical to that of wild-type Flt-1. Furthermore, transfected cells expressing these chimeric Flt-4 receptors exhibited increased DNA synthesis in response to VEGF or PlGF. These results demonstrate that a single Ig-like domain is the major determinant for VEGF-PlGF interaction and that binding to this domain may initiate a signal transduction cascade.
Similar articles
-
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.Cancer Res. 2001 Oct 1;61(19):7002-8. Cancer Res. 2001. PMID: 11585724
-
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.Oncogene. 1995 Jan 5;10(1):135-47. Oncogene. 1995. PMID: 7824266
-
Characterization of the VEGF binding site on the Flt-1 receptor.Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8. doi: 10.1006/bbrc.1999.1282. Biochem Biophys Res Commun. 1999. PMID: 10471394
-
Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
-
Structure-function analyses of the kit receptor for the steel factor.Stem Cells. 1993 Jul;11 Suppl 2:12-21. doi: 10.1002/stem.5530110804. Stem Cells. 1993. PMID: 7691317 Review.
Cited by
-
Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor.Invest New Drugs. 1999;17(3):195-212. doi: 10.1023/a:1006314501634. Invest New Drugs. 1999. PMID: 10665474 Review.
-
Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.Mol Ther Methods Clin Dev. 2022 Jan 10;24:210-221. doi: 10.1016/j.omtm.2022.01.002. eCollection 2022 Mar 10. Mol Ther Methods Clin Dev. 2022. PMID: 35141350 Free PMC article.
-
Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2.J Cell Biol. 2003 Feb 17;160(4):605-15. doi: 10.1083/jcb.200209014. J Cell Biol. 2003. PMID: 12591918 Free PMC article.
-
Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.PLoS One. 2010 Sep 13;5(9):e12682. doi: 10.1371/journal.pone.0012682. PLoS One. 2010. PMID: 20856934 Free PMC article.
-
Vascular endothelial growth factor receptor-2 in breast cancer.Biochim Biophys Acta. 2010 Aug;1806(1):108-21. doi: 10.1016/j.bbcan.2010.04.004. Epub 2010 May 11. Biochim Biophys Acta. 2010. PMID: 20462514 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous